Lmn7.0

Lion's Mane

Lion's Mane Mushroom (Hericium erinaceus)

A unique mushroom that stimulates nerve growth factor (NGF), supporting brain health, cognition, and nerve repair.

mentalcognitionnerve healthmemoryNGF
Last reviewed: January 1, 2025
7.0/10
40+ studies
Evidence
high
Safety
500-3000mg daily
Dose
4-12 weeks
Time to Effect
Fruiting body extract (1:1 or higher)
Best Form

Lion's Mane is a medicinal mushroom with unique compounds (hericenones and erinacines) that stimulate nerve growth factor (NGF) production. This makes it particularly interesting for cognitive health, nerve regeneration, and potentially neuroprotective effects. Benefits may take 4+ weeks to manifest.

Mechanisms of Action

🧠
NGF Stimulation

Increases nerve growth factor production

🌱
Neurogenesis Support

May support growth of new brain cells

🔗
Myelin Support

May support nerve insulation repair

Recommended Dose

500-3000mg daily

500mg3000mg

Optimal Timing

  • Morning with breakfast

Take with food

Best Form

Fruiting body extract (1:1 or higher)

Alternatives: Dual extract (water + alcohol), Powder

CRITICAL: Use fruiting body extract, NOT 'mycelium on grain' which is mostly starch. Look for 1:1 extract ratio or higher. Beta-glucan content should be listed.

Duration

Minimum: 4 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Can be taken any time of day. Morning is common for cognitive benefits throughout the day. Some take divided doses.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🧠
Cognitive Enhancement

Improved memory and mental clarity

4-8 weeks
65% of users notice thispositive
😊
Mood & Anxiety

Reduced anxiety and improved mood

4 weeks
55% of users notice thispositive
⏳
Gradual Effects

Benefits develop slowly over weeks

4-8 weeks
85% of users notice thisneutral
High SafetyMax safe dose: Up to 3g/day commonly used; some studies use higher doses
🔴
Pregnant/nursing

Insufficient safety data; not recommended

🟢
Elderly

May be particularly beneficial for age-related cognitive decline

Who Should NOT Take This

  • Mushroom allergy
  • Bleeding disorders (may affect clotting)

Drug Interactions

Blood thinnersmild

May have mild antiplatelet effects — may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy

Diabetes medicationsmild

May lower blood sugar

Possible Side Effects

Digestive discomfortrare

Tip: Take with food; reduce dose

Skin rash (allergic)uncommon

Tip: Discontinue if occurs; may indicate mushroom allergy

Warnings

  • Must use fruiting body extract, not mycelium on grain
  • Effects take 4+ weeks to develop
  • Quality varies significantly between products

Top studies from 40+ peer-reviewed papers

systematic-review
DOI

Taib NAB et al. • Medical sciences (Basel, Switzerland) (2026)

“Conclusions: Despite presenting the potential use of mushrooms in managing PNIs, the existing approaches need to be subjected to clinical research to accelerate the development of future therapeutics and preventive measures for PNIs.”
Key Findings:
  • Results: These mushroom-derived treatments enhanced the migration of Schwann cells mainly via the FGF-2 signalling and MAPK pathway.
  • In vivo studies also revealed the ability of H. erinaceus, A. muscaria, and L. rhinocerotis to promote peripheral nerve repair and functional recovery, with evidence suggesting the role of neurotrophic factors, anti-apoptotic signalling, and pro-inflammatory substances.
  • H. erinaceus was identified as the most promising for potential clinical applications, given the stronger evidence-based data and its relatively safer components compared to A. muscuria and other mushroom species.
systematic-review
DOI

Contato AG et al. • Nutrients (2025)

“The potential of H. erinaceus as a functional food, nutraceutical, and adjunct therapeutic agent highlights the need for interdisciplinary collaboration between researchers, clinicians, and regulatory bodies.”
Key Findings:
  • Advances in biotechnological methods, including optimized cultivation techniques and novel extraction methods, may further enhance the bioavailability and pharmacological effects of H. erinaceus.
  • Despite promising findings, clinical validation remains limited.
  • Future research should prioritize large-scale clinical trials, the standardization of extraction methods, and the elucidation of pharmacokinetics to facilitate its integration into evidence-based medicine.
  • The potential of H. erinaceus as a functional food, nutraceutical, and adjunct therapeutic agent highlights the need for interdisciplinary collaboration between researchers, clinicians, and regulatory bodies.
systematic-review
DOI

Bentharavithana J et al. • International journal of molecular sciences (2025)

“Further research is needed to elucidate the molecular mechanisms and confirm the safety and efficacy of medicinal mushrooms as a holistic anti-colon cancer treatment.”
Key Findings:
  • Therefore, there is a strong demand for innovative, affordable, and minimally invasive treatments such as medicinal mushrooms.
  • Further research is needed to elucidate the molecular mechanisms and confirm the safety and efficacy of medicinal mushrooms as a holistic anti-colon cancer treatment.
  • Further research warranted to confirm findings
systematic-reviewn=34
DOI

Cha S et al. • Neuroscience and biobehavioral reviews (2024)

“All rights reserved.”
Key Findings:
  • Studies mainly investigated Lion's Mane (Hericium erinaceus), showing some enhancement of mood and cognitive function in middle-aged and older adults.
  • Published by Elsevier Ltd..
  • All rights reserved.
systematic-reviewn=7009
DOI

Kocatürk RR et al. • The International journal of neuroscience (2023)

“Better designed trials with holistic measures are needed to investigate the effect of nutritional support on the AD biomarkers, cognitive status, biochemical parameters and functional states.”
Key Findings:
  • Better designed trials with holistic measures are needed to investigate the effect of nutritional support on the AD biomarkers, cognitive status, biochemical parameters and functional states.
  • Also, more beneficial results can be obtained by examining the simultaneous effects of nutritional supplements with larger sample groups.
  • Further research warranted to confirm findings
39
Total Studies
8.6/10
Avg Quality
30-7,009
Sample Size Range
2008-2026
Research Span

Study Type Distribution

Systematic Review
30
RCT
6
In Vitro
2
Animal
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.